The Tamil Nadu government has prohibited the production, sale, and consumption of the cough syrup ‘Almond Kit’ due to the presence of the harmful chemical ethylene glycol, as confirmed by laboratory tests. The syrup, originating from Bihar, was discovered to be tainted with ethylene glycol, a substance known for causing severe health issues, including acute kidney failure and potential fatality. Authorities have instructed all medical establishments in Tamil Nadu to cease the sale of the contaminated syrup immediately.
The Tamil Nadu Drug Control Directorate has issued a warning about the dangers of consuming the contaminated syrup, emphasizing the risks of brain and lung damage, as well as the possibility of death in extreme cases. The directive extends to medical shops, distributors, hospitals, and pharmacies, mandating the withdrawal of the product from circulation. Consumers are advised to refrain from using the syrup with batch number AL24002 and are urged to contact officials for proper disposal guidance.
In response to the contamination, the Drug Control Directorate has ramped up inspections and surveillance in pharmacies and hospitals across Tamil Nadu to ensure the complete removal of the hazardous syrup from the market. The public is encouraged to reach out to the Directorate via WhatsApp at 94458 65400 for any queries, complaints, or further instructions.
The recent ban echoes past tragedies associated with tainted medicinal syrups in India, particularly incidents involving ethylene glycol or diethylene glycol, resulting in fatalities, especially among children. These events have raised concerns about pharmaceutical quality control, prompting stricter regulatory oversight. Health experts emphasize the lethal nature of ethylene glycol, emphasizing the need for swift regulatory intervention, particularly concerning children’s safety.
Authorities stress their commitment to patient safety and warn of severe legal consequences for violations of the ban. The public is advised to exercise caution when purchasing medicines, verify labels and batch numbers diligently, and report any suspicious or substandard drugs promptly. The government pledges to enhance monitoring mechanisms to prevent future tragedies and ensure the delivery of safe, high-quality medicines to patients.
